Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
‘We cannot just hit the easy button’: AAOS launches pain management resource center
5+ hour, 34+ min ago (69+ words) The American Academy of Orthopaedic Surgeons launched a new online pain management resource center for orthopedic surgeons and patients, according to a press release.“Very few of the organizations in the country have taken a lead on trying to…...
‘Incredibly important’ expanded approvals in pediatric psoriasis
6+ day, 6+ hour ago (186+ words) Dive Deeper by Asking What treatment options are available to pediatric patients with psoriasis? Experts: Eingun James Song, MD Video Released: September 2, 2026 In this video, Eingun James Song, MD, FAAD, discusses two recently expanded approvals of psoriasis treatments in pediatric…...
Taltz, Zepbound combo yields sustained improvement at 1 year in psoriatic disease, obesity
1+ week, 8+ hour ago (54+ words) Adults with moderate to severe psoriatic disease and overweight or obesity saw sustained or continued improvement in disease activity at 1 year with tirzepatide plus ixekizumab vs. ixekizumab monotherapy, according to a Lilly press release.One-year data from the phase 3b, randomized,…...
Opioid use disorder ‘relatively common’ in rheumatic disease
1+ week, 21+ hour ago (63+ words) Although opioid use disorder is “relatively common” in rheumatology settings, fewer than 15% of patients with this disorder and rheumatic disease receive medications to treat it, according to data published in Arthritis Care & Research.“Patients with rheumatic…...
New guidelines outline pharmacological treatment for migraine prevention
1+ week, 1+ day ago (179+ words) New guidelines from the American Academy of Neurology and the American Headache Society are meant to help clinicians provide preventive treatments and medication to adults with migraine more effectively, according to the authors. The updated guidelines incorporate new developments in…...
Deucravacitinib shows ‘superior efficacy’ in psoriatic arthritis at 52 weeks
1+ week, 1+ day ago (58+ words) Deucravacitinib demonstrated “superior efficacy” and tolerability vs. placebo at 16 weeks, and sustained efficacy through 52 weeks, in adults with active psoriatic arthritis, according to data published in Arthritis & Rheumatology. Philip J. Mease, MD, of Swedish Medical Center and the…...
Eye on Efficiency: Ergonomics
1+ week, 5+ day ago (570+ words) Whether in the clinic or in the operating room, ophthalmologists go through a lot of repetitive movements. Over the course of a career, small inconsistencies in posture or support can compound and create problems for a surgeon. “Surgeons perform thousands…...
Denosumab may confer lower osteoarthritis risk than oral bisphosphonates
1+ week, 6+ day ago (58+ words) Older adults with osteoporosis may have decreased risk for osteoarthritis if they initiate therapy with denosumab compared with an oral bisphosphonate, according to study data published in the Journal of Bone and Mineral Research. In a target trial emulation study,…...
One-stage exchange may be noninferior to two-stage exchange for chronic PJI
2+ week, 4+ day ago (215+ words) A one-stage approach to treat patients with periprosthetic joint infections after primary total knee and hip arthroplasty offers noninferior outcomes to two-stage treatment, according to recently published results.“The caveat here is that you have to follow a very…...
FDA approves Pasatru for fibrodysplasia ossificans progressiva
2+ week, 5+ day ago (54+ words) The FDA approved a novel therapy for reducing the formation of heterotopic ossification lesions and flare-ups for adults with fibrodysplasia ossificans progressiva, according to an industry press release.Garetosmab-grts (Pasatru, Regeneron) is a monoclonal antibody administered through IV infusion. According…...